Suppr超能文献

人血激肽-1和人血激肽-1(4-11)(哺乳动物速激肽肽类)对小鼠疼痛调节作用的体内特征研究

In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice.

作者信息

Fu Cai Y, Zhao You L, Dong Li, Chen Qiang, Ni Jing M, Wang Rui

机构信息

State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong.

出版信息

Brain Behav Immun. 2008 Aug;22(6):850-60. doi: 10.1016/j.bbi.2007.12.010. Epub 2008 Feb 8.

Abstract

Human hemokinin-1 (h HK-1) and its truncated form h HK-1(4-11) are mammalian tachykinin peptides encoded by the recently identified TAC4 gene in human, and the biological functions of these peptides have not been well investigated. In the present study, an attempt has been made to investigate the effects and mechanisms of action of h HK-1 and h HK-1(4-11) in pain modulation at the supraspinal level in mice using the tail immersion test. Intracerebroventricular (i.c.v.) administration of h HK-1 (0.3, 1, 3 and 6 nmol/mouse) produced a dose- and time-related antinociceptive effect. This effect was significantly antagonized by the NK(1) receptor antagonist SR140333, but not by the NK(2) receptor antagonist SR48968, indicating that the analgesic effect induced by i.c.v. h HK-1 is mediated through the activation of NK(1) receptors. Interestingly, naloxone, beta-funaltrexamine and naloxonazine, but not naltrindole and nor-binaltorphimine, could also block the analgesic effect markedly, suggesting that this effect is related to descending mu opioidergic neurons (primary mu(1) subtype). Human HK-1(4-11) could also induce a dose- and time-dependent analgesic effect after i.c.v. administration, however, the potency of analgesia was less than h HK-1. Surprisingly, SR140333 could not modify this analgesic effect, suggesting that this effect is not mediated through the NK(1) receptors like h HK-1. SR48968 could modestly enhance the analgesic effect induced by h HK-1(4-11), indicating that a small amount of h HK-1(4-11) may bind to NK(2) receptors. Furthermore, none of the opioid receptor (OR) antagonists could markedly block the analgesia of h HK-1(4-11), suggesting that the analgesic effect is not mediated through the descending opioidergic neurons. Blocking of delta ORs significantly enhanced the analgesia, indicating that delta OR is a negatively modulatory factor in the analgesic effect of h HK-1(4-11). It is striking that bicuculline (a competitive antagonist at GABA(A) receptors) effectively blocked the analgesia induced by h HK-1(4-11), suggesting that this analgesic effect is mediated through the descending inhibitory GABAergic neurons. The novel mechanism involved in the analgesic effect of h HK-1(4-11), which is different from that of h HK-1, may pave the way for a new strategy for the investigation and control of pain.

摘要

人血激肽 -1(h HK-1)及其截短形式h HK-1(4 - 11)是由人类最近鉴定出的TAC4基因编码的哺乳动物速激肽肽,这些肽的生物学功能尚未得到充分研究。在本研究中,我们尝试通过尾部浸没法研究h HK-1和h HK-1(4 - 11)在小鼠脊髓上水平疼痛调节中的作用及作用机制。脑室内(i.c.v.)注射h HK-1(0.3、1、3和6 nmol/只小鼠)产生剂量和时间相关的镇痛作用。这种作用被NK(1)受体拮抗剂SR140333显著拮抗,但未被NK(2)受体拮抗剂SR48968拮抗,表明i.c.v. h HK-1诱导的镇痛作用是通过NK(1)受体的激活介导的。有趣的是,纳洛酮、β-氟纳曲酮和纳洛嗪,但不是纳曲吲哚和去甲双氢吗啡酮,也能显著阻断镇痛作用,表明这种作用与下行的μ阿片能神经元(主要是μ(1)亚型)有关。脑室内注射人HK-1(4 - 11)后也能诱导剂量和时间依赖性的镇痛作用,然而,镇痛效力低于h HK-1。令人惊讶的是,SR140333不能改变这种镇痛作用,表明这种作用不像h HK-1那样通过NK(1)受体介导。SR48968能适度增强h HK-1(4 - 11)诱导的镇痛作用,表明少量的h HK-1(4 - 11)可能与NK(2)受体结合。此外,没有一种阿片受体(OR)拮抗剂能显著阻断h HK-1(4 - 11)的镇痛作用,表明镇痛作用不是通过下行阿片能神经元介导的。阻断δ阿片受体显著增强了镇痛作用,表明δ阿片受体是h HK-1(4 - 11)镇痛作用的负调节因子。引人注目的是,荷包牡丹碱(一种GABA(A)受体竞争性拮抗剂)有效地阻断了h HK-1(4 - 11)诱导的镇痛作用,表明这种镇痛作用是通过下行抑制性GABA能神经元介导的。h HK-1(4 - 11)镇痛作用涉及的新机制不同于h HK-1,这可能为疼痛研究和控制的新策略铺平道路。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验